NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer Status COMPLETED Phase PHASE2
NCT00017641 Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE1
NCT00017628 Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT00017381 Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma Status COMPLETED Phase EARLY_PHASE1
NCT00017368 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma Status COMPLETED Phase PHASE2
NCT00017355 Vaccine Therapy in Treating Patients With Metastatic Melanoma Status UNKNOWN Phase PHASE1
NCT00017225 Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma Status COMPLETED Phase PHASE2
NCT00017160 Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma Status WITHDRAWN Phase PHASE2
NCT00017095 Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer Status COMPLETED Phase PHASE3
NCT00016887 Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma Status UNKNOWN Phase PHASE3
NCT00016406 S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT00016341 Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer Status TERMINATED Phase PHASE3
NCT00016159 Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia Status COMPLETED Phase PHASE2
NCT00015938 S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00014755 Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT00014573 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer Status COMPLETED Phase PHASE2
NCT00014534 Combination Chemotherapy in Treating Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00014495 Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00014456 Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00014222 Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer Status COMPLETED Phase PHASE3